Landry, Russell P <br/><br/>
Spinal cannabinoid receptor type 2 agonist reduces mechanical allodynia and induces mitogen-activated protein kinase phosphatases in a rat model of neuropathic pain.  [electronic resource] 

 -  The journal of pain  Sep 2012 
 - 836-48 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-8447 
<br/><br/><label>Standard No.: </label>10.1016/j.jpain.2012.05.013  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>4-Nitrophenylphosphatase--metabolism<br/>Animals<br/>Disease Models, Animal<br/>Diterpenes--therapeutic use<br/>Dual Specificity Phosphatase 1--metabolism<br/>Dual Specificity Phosphatase 6--metabolism<br/>Epoxy Compounds--therapeutic use<br/>Gene Expression Regulation--drug effects<br/>Hyperalgesia--drug therapy<br/>Immunosuppressive Agents--therapeutic use<br/>Indoles--pharmacology<br/>Male<br/>Mitogen-Activated Protein Kinase Phosphatases--classification<br/>Nerve Tissue Proteins--metabolism<br/>Neuralgia--complications<br/>Phenanthrenes--therapeutic use<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptor, Cannabinoid, CB2--agonists<br/>Signal Transduction--drug effects<br/>Spinal Cord--drug effects<br/>Time Factors